Clever Leaves Holdings Inc (CLVR)
3.00
+0.89
(+42.18%)
USD |
NASDAQ |
May 16, 16:00
2.96
-0.04
(-1.33%)
After-Hours: 20:00
Clever Leaves Holdings Enterprise Value: -0.3486M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -0.3486M |
| May 15, 2024 | -1.910M |
| May 14, 2024 | -1.296M |
| May 13, 2024 | -1.419M |
| May 10, 2024 | -1.559M |
| May 09, 2024 | -1.279M |
| May 08, 2024 | -0.9979M |
| May 07, 2024 | -2.103M |
| May 06, 2024 | -2.490M |
| May 03, 2024 | -2.630M |
| May 02, 2024 | -2.577M |
| May 01, 2024 | -2.910M |
| April 30, 2024 | -2.867M |
| April 29, 2024 | -2.770M |
| April 26, 2024 | 1.599M |
| April 25, 2024 | 1.182M |
| April 24, 2024 | 1.283M |
| April 23, 2024 | 1.196M |
| April 22, 2024 | 1.117M |
| April 19, 2024 | 1.548M |
| April 18, 2024 | 1.573M |
| April 17, 2024 | 1.810M |
| April 16, 2024 | 2.355M |
| April 15, 2024 | 2.520M |
| April 12, 2024 | 2.336M |
| Date | Value |
|---|---|
| April 11, 2024 | 3.201M |
| April 10, 2024 | 3.021M |
| April 09, 2024 | 2.825M |
| April 08, 2024 | 2.915M |
| April 05, 2024 | 3.336M |
| April 04, 2024 | 3.503M |
| April 03, 2024 | 3.722M |
| April 02, 2024 | 3.249M |
| April 01, 2024 | 3.214M |
| March 28, 2024 | 2.933M |
| March 27, 2024 | 2.986M |
| March 26, 2024 | 3.038M |
| March 25, 2024 | 2.213M |
| March 22, 2024 | 2.459M |
| March 21, 2024 | 0.5465M |
| March 20, 2024 | 1.231M |
| March 19, 2024 | 1.231M |
| March 18, 2024 | 0.7622M |
| March 15, 2024 | 0.1402M |
| March 14, 2024 | 0.2266M |
| March 13, 2024 | 0.3372M |
| March 12, 2024 | 0.4683M |
| March 11, 2024 | 0.1057M |
| March 08, 2024 | 0.1055M |
| March 07, 2024 | 0.5203M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.910M
Minimum
May 01 2024
9.292B
Maximum
Apr 09 2021
786.60M
Average
15.34M
Median
Enterprise Value Benchmarks
| Tilray Brands Inc | 1.898B |
| Flora Growth Corp | 11.47M |
| Acasti Pharma Inc | 0.8274M |
| Aurinia Pharmaceuticals Inc | 474.73M |
| Edesa Biotech Inc | 11.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.085M |
| Revenue (Quarterly) | 4.638M |
| Total Expenses (Quarterly) | 9.55M |
| EPS Diluted (Quarterly) | -2.95 |
| Gross Profit Margin (Quarterly) | -7.46% |
| Profit Margin (Quarterly) | -109.6% |
| Earnings Yield | -376.7% |
| Normalized Earnings Yield | -325.68 |